Severity grading of microvascular invasion predicts oncological outcomes following hepatectomy for unresectable hepatocellular carcinoma converted by tyrosine kinase inhibitors plus anti-PD-1 antibodies
Shichuan Tang, Tingfeng Huang, Xu Zheng, Zhaohui Cui, Danna Liu, Shaoxian Peng, Jie Kong, Cong Luo, Ruilin Fan, Luobin Guo, Kailing Zhang, Qizhu Lin, Jun Fu, Liqing Zheng, Yongyi Zeng
Springer Nature ·
2026-10-08
· DOI 10.1186/s12885-026-17057-0
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Shichuan Tang, Tingfeng Huang, Xu Zheng, Zhaohui Cui, Danna Liu, Shaoxian Peng et al. Severity grading of microvascular invasion predicts oncological outcomes following hepatectomy for unresectable hepatocellular carcinoma converted by tyrosine kinase inhibitors plus anti-PD-1 antibodies. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-17057-0. – URL: https://doi.org/10.1186/s12885-026-17057-0
Shichuan Tang, Tingfeng Huang, Xu Zheng, Zhaohui Cui, Danna Liu, Shaoxian Peng, Jie Kong, Cong Luo, Ruilin Fan, Luobin Guo, Kailing Zhang, Qizhu Lin, Jun Fu, Liqing Zheng, & Yongyi Zeng (2026). Severity grading of microvascular invasion predicts oncological outcomes following hepatectomy for unresectable hepatocellular carcinoma converted by tyrosine kinase inhibitors plus anti-PD-1 antibodies. BMC Cancer. https://doi.org/10.1186/s12885-026-17057-0
Shichuan Tang, et al. “Severity grading of microvascular invasion predicts oncological outcomes following hepatectomy for unresectable hepatocellular carcinoma converted by tyrosine kinase inhibitors plus anti-PD-1 antibodies.” BMC Cancer, 2026. doi:10.1186/s12885-026-17057-0.
@article{Tang2026,
title = {Severity grading of microvascular invasion predicts oncological outcomes following hepatectomy for unresectable hepatocellular carcinoma converted by tyrosine kinase inhibitors plus anti-PD-1 antibodies},
author = {Tang, Shichuan and Huang, Tingfeng and Zheng, Xu and Cui, Zhaohui and Liu, Danna and Peng, Shaoxian and Kong, Jie and Luo, Cong and Fan, Ruilin and Guo, Luobin and Zhang, Kailing and Lin, Qizhu and Fu, Jun and Zheng, Liqing and Zeng, Yongyi},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-17057-0},
url = {https://doi.org/10.1186/s12885-026-17057-0}
}